Icon Plc (ICLR)

$175.00 -0.11 (-0.06%)
Market Cap 14.14B
Revenue (ttm) 8.28B
Net Income (ttm) 791.47M
EPS (ttm) N/A
PE Ratio 12.85
Forward PE 13.05
Profit Margin 9.56%
Debt to Equity Ratio 0.36
Volume 1,597,300
Avg Vol 1,337,764
Day's Range N/A - N/A
Shares Out 80.76M
Stochastic %K 65%
Beta 1.20
Analysts Strong Sell
Price Target $211.87

Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and p...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 353 1 291 2000
Fax: 353 1 247 6260
Address:
South County Business Park, Leopardstown, Dublin, Ireland
RunnerSignals
RunnerSignals Sep. 12 at 4:05 AM
Daily Market Pulse $ORCL $WDC $LION $ICLR $CLF dancing to new highs with party in the charts! https://stocksrunner.com/news/2025-09-11-daily-market-pulse-advanced-technical-analysis-for-key-stock-trading-strategies
0 · Reply
topstockalerts
topstockalerts Sep. 9 at 7:29 PM
Jefferies upgraded IQVIA Holdings and Charles River Laboratories to Buy while cutting ICON to Hold. IQVIA was named top pick, with stronger client wins, stable trends, and less reliance on single customers; price target raised to $225. ICON faces client losses, project cancellations near $ 1B in Q3, and biotech weakness, leading to a price target cut to $175. Charles River gained on stronger bookings, safety-testing demand, and potential value from a manufacturing unit sale, with a $195 target. Jefferies stayed cautious on Medpace (valuation) and Fortrea (execution risks). $IQV $CRL $ICLR $ICON
1 · Reply
anachartanalyst
anachartanalyst Sep. 9 at 12:02 PM
$ICLR https://anachart.com/wp-content/uploads/ana_temp/1757419294_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 11:00 AM
Jefferies has updated their rating for Icon ( $ICLR ) to Hold with a price target of 175.
0 · Reply
DonCorleone77
DonCorleone77 Sep. 4 at 3:51 PM
$ICLR Icon confirms financial guidance for FY25
0 · Reply
smartkarma
smartkarma Jul. 30 at 11:05 AM
$ICLR | ICON plc: Initiation of Coverage- Capitalizing On Opportunities in China, A Critical Growth Market! "ICON Plc's second-quarter results for 2025 reveal a mixed landscape in the clinical development sector. The company reported revenue of $2.017..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/icon-plc-initiation-of-coverage-capitalizing-on-opportunities-in-china-a-critical-growth-market
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 5:26 PM
Mizuho has adjusted their stance on Icon ( $ICLR ), setting the rating to Outperform with a target price of 173 → 225.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 3:28 PM
UBS has adjusted their stance on Icon ( $ICLR ), setting the rating to Buy with a target price of 170 → 240.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 2:42 PM
Barclays has updated their rating for Icon ( $ICLR ) to Equal-Weight with a price target of 180.
0 · Reply
Iluvoptions85
Iluvoptions85 Jul. 25 at 1:40 PM
$ICLR $185 eod?!?! 🧐
0 · Reply
Latest News on ICLR
ICON Announces CEO Transition

Sep 4, 2025, 8:00 AM EDT - 8 days ago

ICON Announces CEO Transition

ICON plc to Participate at Upcoming Investor Conferences

Sep 2, 2025, 6:00 AM EDT - 10 days ago

ICON plc to Participate at Upcoming Investor Conferences

ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 6:21 PM EDT - 7 weeks ago

ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript

ICON: Lower Guidance Downside And Expanded Repurchase Plan

Jul 24, 2025, 7:00 AM EDT - 7 weeks ago

ICON: Lower Guidance Downside And Expanded Repurchase Plan

ICON Announces Results of Annual General Meeting

Jul 23, 2025, 4:20 PM EDT - 7 weeks ago

ICON Announces Results of Annual General Meeting

ICON Reports Second Quarter 2025 Results

Jul 23, 2025, 4:15 PM EDT - 7 weeks ago

ICON Reports Second Quarter 2025 Results

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

Jul 16, 2025, 7:15 AM EDT - 2 months ago

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

Jul 7, 2025, 7:15 AM EDT - 2 months ago

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?

Jun 25, 2025, 6:36 AM EDT - 2 months ago

ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

Jun 23, 2025, 6:30 AM EDT - 2 months ago

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

Jun 2, 2025, 4:12 AM EDT - 3 months ago

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 27, 2025, 8:30 AM EDT - 3 months ago

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON releases its ICON Cares 2024 Report

May 19, 2025, 4:15 PM EDT - 4 months ago

ICON releases its ICON Cares 2024 Report

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

May 7, 2025, 7:27 AM EDT - 4 months ago

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript

May 2, 2025, 2:42 AM EDT - 4 months ago

ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript

ICON Reports First Quarter 2025 Results

Apr 30, 2025, 4:15 PM EDT - 4 months ago

ICON Reports First Quarter 2025 Results

GreensKeeper Q1 2025 Portfolio Update

Apr 10, 2025, 8:55 AM EDT - 5 months ago

GreensKeeper Q1 2025 Portfolio Update

AXP CHKP ELV GOOG GOOGL ICE VRTX

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ICON

Apr 4, 2025, 3:45 AM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ICON

ICON plc Schedules First Quarter 2025 Earnings Conference Call

Mar 31, 2025, 6:30 AM EDT - 5 months ago

ICON plc Schedules First Quarter 2025 Earnings Conference Call

BetterInvesting™ Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR)

Mar 24, 2025, 5:09 PM EDT - 6 months ago

BetterInvesting™ Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR)

LOW

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review

Mar 20, 2025, 4:00 AM EDT - 6 months ago

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR

Mar 17, 2025, 5:45 AM EDT - 6 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Lawsuit - ICLR

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Public Limited Company Lawsuit - ICLR

Mar 6, 2025, 5:45 AM EST - 6 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 11, 2025 in ICON Public Limited Company Lawsuit - ICLR

ICON plc to Present at Upcoming Investor Conferences

Mar 5, 2025, 7:30 AM EST - 6 months ago

ICON plc to Present at Upcoming Investor Conferences

ICLR REMINDER: ICON plc was Sued for Securities Fraud; Investors are Alerted to Contact BFA Law before April 11 Deadline (NASDAQ:ICLR)

Mar 2, 2025, 7:28 AM EST - 6 months ago

ICLR REMINDER: ICON plc was Sued for Securities Fraud; Investors are Alerted to Contact BFA Law before April 11 Deadline (NASDAQ:ICLR)

Shareholders of ICON Public Limited Company Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR

Feb 27, 2025, 5:45 AM EST - 7 months ago

Shareholders of ICON Public Limited Company Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR

Robbins LLP Reminds ICON PLC (ICLR) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Feb 26, 2025, 8:56 PM EST - 7 months ago

Robbins LLP Reminds ICON PLC (ICLR) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Kessler Topaz Meltzer & Check, LLP Encourages ICON Public Limited Company Investors with Losses to Contact the Firm

Feb 24, 2025, 6:30 PM EST - 7 months ago

Kessler Topaz Meltzer & Check, LLP Encourages ICON Public Limited Company Investors with Losses to Contact the Firm

ICON: An Excellent Investment Opportunity With Strong Growth Potential

Feb 24, 2025, 1:27 PM EST - 7 months ago

ICON: An Excellent Investment Opportunity With Strong Growth Potential

ICLR SECURITIES NEWS: ICON plc has been Sued for Securities Fraud - Investors are Alerted to Contact BFA Law by April 11 Legal Deadline (NASDAQ:ICLR)

Feb 21, 2025, 3:17 PM EST - 7 months ago

ICLR SECURITIES NEWS: ICON plc has been Sued for Securities Fraud - Investors are Alerted to Contact BFA Law by April 11 Legal Deadline (NASDAQ:ICLR)

RunnerSignals
RunnerSignals Sep. 12 at 4:05 AM
Daily Market Pulse $ORCL $WDC $LION $ICLR $CLF dancing to new highs with party in the charts! https://stocksrunner.com/news/2025-09-11-daily-market-pulse-advanced-technical-analysis-for-key-stock-trading-strategies
0 · Reply
topstockalerts
topstockalerts Sep. 9 at 7:29 PM
Jefferies upgraded IQVIA Holdings and Charles River Laboratories to Buy while cutting ICON to Hold. IQVIA was named top pick, with stronger client wins, stable trends, and less reliance on single customers; price target raised to $225. ICON faces client losses, project cancellations near $ 1B in Q3, and biotech weakness, leading to a price target cut to $175. Charles River gained on stronger bookings, safety-testing demand, and potential value from a manufacturing unit sale, with a $195 target. Jefferies stayed cautious on Medpace (valuation) and Fortrea (execution risks). $IQV $CRL $ICLR $ICON
1 · Reply
anachartanalyst
anachartanalyst Sep. 9 at 12:02 PM
$ICLR https://anachart.com/wp-content/uploads/ana_temp/1757419294_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Sep. 9 at 11:00 AM
Jefferies has updated their rating for Icon ( $ICLR ) to Hold with a price target of 175.
0 · Reply
DonCorleone77
DonCorleone77 Sep. 4 at 3:51 PM
$ICLR Icon confirms financial guidance for FY25
0 · Reply
smartkarma
smartkarma Jul. 30 at 11:05 AM
$ICLR | ICON plc: Initiation of Coverage- Capitalizing On Opportunities in China, A Critical Growth Market! "ICON Plc's second-quarter results for 2025 reveal a mixed landscape in the clinical development sector. The company reported revenue of $2.017..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/icon-plc-initiation-of-coverage-capitalizing-on-opportunities-in-china-a-critical-growth-market
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 5:26 PM
Mizuho has adjusted their stance on Icon ( $ICLR ), setting the rating to Outperform with a target price of 173 → 225.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 3:28 PM
UBS has adjusted their stance on Icon ( $ICLR ), setting the rating to Buy with a target price of 170 → 240.
0 · Reply
JarvisFlow
JarvisFlow Jul. 25 at 2:42 PM
Barclays has updated their rating for Icon ( $ICLR ) to Equal-Weight with a price target of 180.
0 · Reply
Iluvoptions85
Iluvoptions85 Jul. 25 at 1:40 PM
$ICLR $185 eod?!?! 🧐
0 · Reply
Iluvoptions85
Iluvoptions85 Jul. 24 at 4:13 PM
$ICLR Down some more please! PUTS are PRINTING!!! 🤑
0 · Reply
Iluvoptions85
Iluvoptions85 Jul. 24 at 2:25 PM
$ICLR PUTS!!!!! 🤑
0 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 24 at 2:08 PM
$ICLR cranking up 🚀🚀🚀🚀
0 · Reply
bnzmon
bnzmon Jul. 24 at 2:08 PM
$ICLR incoming!!!
0 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 24 at 2:08 PM
$ICLR short squeeeeeeeze
0 · Reply
bnzmon
bnzmon Jul. 24 at 1:58 PM
$ICLR do we get a squeeze?
0 · Reply
stockwatcherking
stockwatcherking Jul. 24 at 1:56 PM
$ICLR Call outs paid big here. All out on that pp to $210 this AM. She could run higher. Anyone looking for a $MEDP like move, remember the float and short interest here are very different. Don't expect the same kind of move.
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 24 at 1:37 PM
$ZOOZ 13%[2%] $SLDP 11%[14%] $CRE -7%[-9%] $YYAI 6%[10%] $ICLR -5%[19%] most notable movement within the first minutes of trading.
0 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 24 at 1:33 PM
$ICLR 220 in play 💸
0 · Reply
1986iamwallstreet
1986iamwallstreet Jul. 24 at 11:39 AM
$ICLR short squeeze to 200+
0 · Reply
JarvisFlow
JarvisFlow Jul. 24 at 11:30 AM
Baird has adjusted their stance on Icon ( $ICLR ), setting the rating to Outperform with a target price of 150 → 224.
0 · Reply
InItToWinIt100
InItToWinIt100 Jul. 24 at 12:15 AM
A few of the many names I will have eyes on pre market tomorrow: $MXL Watch for push to $20 $ICLR Come on $200 $TREE Gap fill room to $51.77 $IBM Watch for bounce $CMG $44.61 target
2 · Reply